ExTherea Inc, Fujisawa, Kanagawa, Japan.
Department of Clinical Sciences, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden.
Adv Exp Med Biol. 2021;1312:131-138. doi: 10.1007/5584_2020_599.
Extracellular vesicles (EVs) are nano-sized, cell-released vesicles which contain lipids, proteins, and nucleic acids derived from the parental cells. EVs play an important role in intercellular communication and influence both physiological and pathological conditions. They are increasingly explored as potential therapeutic agents since they can cross biological barriers, their cargo is protected from degradation and they are involved in the transfer of bioactive components. EVs can promote tissue regeneration and might be alternatives to cell therapy. They can be used both in their native form, and as delivery vehicles for therapeutic agents. However, there are many hurdles to overcome for broad clinical application of EVs as therapeutics. Here, we review recent conditions regarding EVs therapeutics in regenerative medicine.
细胞外囊泡(EVs)是纳米大小的、由细胞释放的囊泡,其中包含源自亲代细胞的脂质、蛋白质和核酸。EVs 在细胞间通讯中发挥着重要作用,并影响生理和病理状态。由于它们可以穿越生物屏障、其货物免受降解、并参与生物活性成分的传递,因此它们被越来越多地探索作为潜在的治疗剂。EVs 可以促进组织再生,并且可能替代细胞治疗。它们可以以天然形式使用,也可以作为治疗剂的递送载体。然而,要将 EVs 广泛应用于治疗领域,还有许多障碍需要克服。在这里,我们综述了再生医学中 EVs 治疗的最新情况。